Lytgobi 4 mg, Filmtabletten

7680697140017 CH-69714 Filmtabletten
Lytgobi 4 mg, Filmtabletten
Lytgobi 4 mg, Filmtabletten
Lytgobi 4 mg, Filmtabletten
1 / 3
google

Article details

Package size
21
Selling units
21
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/09/2025
Summary of Product Characteristics
Français
13/09/2025
Summary of Product Characteristics
Italien
13/09/2025
Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
4.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
0.3196 MG Substance HBESI
(N/A)
5.4 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
43.6 MG Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Taiho Oncology Europe GmbH

6340 Baar

Authorization information

Swissmedic authorization number
69714
Drug name
Lytgobi, Filmtabletten
Galenic form
FILM
ATC Code
L01EN04
Authorization status
B
Dispensing category
A
First authorization
08/10/2024
Authorization expiration date
08/10/2026
IT Number
07.16.1.
Domain
Human medicine
Field of application
Cholangiokarzinom

Package details

Description (FR)
LYTGOBI cpr pellic 4 mg 21 pce
Description (DE)
LYTGOBI Filmtabl 4 mg 21 Stk
Market launch
31/12/2028
Narcotic (BTM)
No

Other package sizes (2)

LYTGOBI cpr pellic 4 mg 28 pce
28 TABL
GTIN: 7680697140024
View
LYTGOBI cpr pellic 4 mg 35 pce
35 TABL
GTIN: 7680697140031
View